Data Protection Notice

Additional Data Protection Notice for the Adverse Drug Reaction Reporting Form

We are a corporate group headquartered in Germany whose principal activity is pharmaceutical manufacturing, amongst other. This Additional Data Protection Notice covers Grünenthal GmbH. It describes how Grünenthal collects and handles personal data that is provided to Grünenthal in connection with adverse drug reaction reporting based on this form.

We kindly ask you to read this Additional Data Protection Notice before submitting information. Please also read the General Privacy Statement of Grünenthal.

By submitting information via the Adverse Drug Reaction Reporting Form, you acknowledge that you understand and agree to the terms of this Additional Data Protection Notice.

Purpose of Data Collection

The personal data that you provide when filling the Grünenthal Adverse Drug Reaction Reporting Form is related to your experience with using any of our products. We will use the data in order to analyze the safety and the effectiveness of Grünenthal products and to comply with our reporting obligations towards Health Authorities. Grünenthal may also use this information to fulfill any further legal obligation, especially but not limited to regulatory requirement.

In order to follow up with the adverse event(s) reported via the Adverse Drug Reaction Reporting Form, it may happen that we deem it reasonable to contact you and ask for permission to clarify medical conditions with your treating healthcare professionals. You may consent to this follow up by indicating this in the corresponding box at the end of the Adverse Drug Reaction Reporting Form..

Data Disclosure to Third Parties

We may transfer your personal data to other parties within and outside of the EU:

• Grünenthal affiliates if required for the aforementioned purposes. This Additional Data Protection Notice covers web sites of affiliated companies hosted by Grünenthal.
• Third party service providers to which Grünenthal delegates activities in accordance with the aforementioned purpose of the data collection. These service providers have agreed on a confidentiality agreement, which prohibits use of your personal data for any other purpose(s) than the contracted one(s), and further disclosure unless required or authorized by Grünenthal.
• Third party companies to which we sell or licensed our products only in accordance with the aforementioned purpose of the data collection. Prior to such disclosure we would require these companies to comply with the terms of this Additional Data Protection Notice.
• Health Authorities and any governmental if required by applicable legislation, especially but not limited to regulatory regulations.

Data Security

Your personal data are sent to us via a secure transmission method that is state of the art (SSL certificate) in order to protect security and confidentiality of your personal data collected in this Adverse Drug Reaction Reporting Form.

Your personal data are stored temporarily on a server located in Germany and controlled by Grünenthal.

The recipient of your personal data is located in Germany.

Grünenthal reserves the rights to amend this Additional Data Protection Notice at any time.

If the Additional Data Protection Notice accompanying the Adverse Drug Reaction Reporting Form changes, the revised notice will be posted here. This Additional Data Protection Notice was last updated in May 2015.

Contact information and request related to data privacy:

If you have an enquiry or concern about our Additional Data Protection Notice, please contact:

online:  26 May 2015